Measures · D08 in 2024 · Part D · DD4 Drug Safety and Accuracy of Drug Pricing
Medication Adherence for Diabetes Medications
Drug PlanMedication AdherenceSource: Prescription Drug Events
- What it measures
- Percent of plan members with a prescription for diabetes medication who fill their prescription often enough to cover 80% or more of the time they are supposed to be taking the medication. One of the most important ways people with diabetes can manage their health is by taking their medication as directed. The plan, the doctor, and the member can work together to find ways to do this. (“Diabetes medication” means a biguanide drug, a sulfonylurea drug, a thiazolidinedione drug, a DPP-4 inhibitor, a GLP-1 receptor agonist, a meglitinide drug, or an SGLT2 inhibitor. Plan members who take insulin are not included.)
- How it's calculated
- This measure is defined as the percent of Medicare Part D beneficiaries 18 years and older who adhere to their prescribed drug therapy across classes of diabetes medications: biguanides, sulfonylureas, thiazolidinediones, DiPeptidyl Peptidase (DPP)- 4 Inhibitors, GLP-1 receptor agonists, meglitinides, and sodium glucose cotransporter 2 (SGLT2) inhibitors. This percentage is calculated as the number of member-years of enrolled beneficiaries 18 years and older with a proportion of days covered (PDC) at 80 percent or higher across the classes of diabetes medications during the measurement period (numerator) divided by the number of member-years of enrolled beneficiaries 18 years and older with at least two fills of diabetes medication(s) on unique dates of service during the measurement period (denominator). The PDC is the percent of days in the measurement period “covered” by prescription claims for the same medication or another in its therapeutic category. Beneficiaries are only included in the measure calculation if the first fill of their diabetes medication occurs at least 91 days before the end of the enrollment period. The Medication Adherence measure is adapted from the Medication Adherence- Proportion of Days Covered measure that was developed and endorsed by the Pharmacy Quality Alliance (PQA). See the medication list for this measure. The Medication Adherence rate is calculated using the National Drug Code (NDC) list maintained by the PQA. The complete NDC list, including diagnosis codes, is posted along with these technical notes.
- Data source
- Prescription Drug Event (PDE) data The data for this measure come from PDE data submitted by drug plans to CMS Drug Data Processing Systems (DDPS) and accepted by the 2022 PDE submission deadline for annual Part D payment reconciliation with dates of service from January 1, 2022- December 31, 2022. If the PDE edit results in the PDE being rejected by DDPS, then the PDE is not used in the Patient Safety measure calculations. If the PDE edit is informational and therefore, does not result in the PDE being rejected, then the PDE is used in the Patient Safety measure calculations. Reminder, CMS uses the term “final action” PDE to describe the most recently accepted original, adjustment, or deleted PDE record representing a single dispensing event. Original and adjustment final action PDEs submitted by the sponsor and accepted by DDPS prior to the 2022 PDE submission deadline are used to calculate this measure. PDE claims are limited to members who received at least two prescriptions on unique dates of service for diabetes medication(s). PDE adjustments made post-reconciliation were not reflected in this measure. Additional data sources include the Common Medicare Environment (CME), the Medicare Enrollment Database (EDB), the Common Working File (CWF), and the Encounter Data Systems (EDS). • CME is used for enrollment information. • EDB is used for hospice enrollment and ESRD status (dialysis start and end dates within the measurement period). • CWF is used to identify exclusion diagnoses based on ICD-10-CM codes, inpatient (IP) and skilled nursing facility (SNF) stays for PDPs and MA-PDs (if available). • EDS is used to identify diagnoses based on ICD-10-CM codes, and SNF/IP stays for MA-PD beneficiaries.
- Measurement period
- 01/01/2022 – 12/31/2022
- Better when
- Higher
- Weight
- 3 (Intermediate Outcome Measure)
- Star assignment
- Clustering
- Case-mix adjusted
- No
- In improvement measure
- Yes
- Used in CAI
- Yes
- Exclusions
Show
Contracts with 30 or fewer enrolled member-years (in the denominator). The following beneficiaries are also excluded from the denominator if at any time during the measurement period: • Hospice enrollment • ESRD diagnosis or dialysis coverage dates • One or more prescriptions for insulin- Notes
- Part D drugs do not include drugs or classes of drugs, or their medical uses, which may be excluded from coverage or otherwise restricted under section 1927(d)(2) of the Act, except for smoking cessation agents. As such, these drugs, which may be included in the PQA medication or NDC lists, are excluded from CMS analyses. Also, the member- years of enrollment adjustment is made by CMS to account for partial enrollment within the benefit year. Enrollment is measured at the episode level, and inclusion in the measure is determined separately for each episode – i.e., to be included for a given episode, the beneficiary must meet the initial inclusion criteria for the measure during that episode. The measure is weighted based on the total number of member-years for each enrollment episode in which the beneficiary meets the measure criteria. For instance, if a beneficiary is enrolled for a three-month episode, disenrolled for a six-month episode, reenrolled for a three-month episode, and meets the measure criteria during each enrollment episode, s/he will count as 0.5 member years in the rate calculation (3/12 + 3/12 = 6/12). The PDC calculation is adjusted for overlapping prescriptions for the same drug which is defined by the active ingredient at the generic name level using the NDC list maintained by PQA. The calculation also adjusts for Part D beneficiaries’ stays in inpatient (IP) settings, and stays in skilled nursing facilities (SNFs). The discharge date is included as an adjustment for IP/SNF stays. Please see Attachment L: Medication Adherence Measure Calculations for more information about these calculation adjustments. When available, beneficiary death date from the CME is the end date of a beneficiary’s measurement period.
- Disaster policy
- Higher measure star (2023-2024) for contracts with 25% or more enrolled affected by 2022 disasters.
From the 2024 Star Ratings Technical Notes (CMS).
Cut points over time
Score needed to earn each star level. Part D thresholds differ for MA-PD and standalone PDP contracts. Dotted lines and open dots: where the cut points may move for 2028.
How the 2028 cut points are projected
Each boundary moves by its median year-on-year change since 2019, capped at 5 points, the most CMS lets a non-survey cut point move in a year. It's the same projection the Star outlook uses for every contract. CMS sets real cut points from all contracts' scores each year, so treat these as a direction, not a forecast of the exact number.
| Stars | Org type | 2027 | Projected 2028 | Move |
|---|---|---|---|---|
| 2★ | MA-PD | 86 | 88 | +2 |
| 3★ | MA-PD | 89 | 90 | +1 |
| 4★ | MA-PD | 91 | 92 | +1 |
| 5★ | MA-PD | 93 | 94 | +1 |
| 2★ | PDP | 86 | 86 | 0 |
| 3★ | PDP | 88 | 88 | 0 |
| 4★ | PDP | 90 | 90 | 0 |
| 5★ | PDP | 95 | 95 | 0 |
2024 star distribution
Not rated: Plan too new to be measured (96); Not enough data available (63); No data available (29); Plan not required to report measure (5)
Cut point bands
| Star year | Org type | 1★ | 2★ | 3★ | 4★ | 5★ |
|---|---|---|---|---|---|---|
| 2027 | MA-PD | < 86 % | >= 86 % to < 89 % | >= 89 % to < 91 % | >= 91 % to < 93 % | >= 93 % |
| 2027 | PDP | < 86 % | >= 86 % to < 88 % | >= 88 % to < 90 % | >= 90 % to < 95 % | >= 95 % |
| 2026 | MA-PD | < 83 % | >= 83 % to < 86 % | >= 86 % to < 89 % | >= 89 % to < 92 % | >= 92 % |
| 2026 | PDP | < 85 % | >= 85 % to < 87 % | >= 87 % to < 89 % | >= 89 % to < 92 % | >= 92 % |
| 2025 | MA-PD | < 80 % | >= 80 % to < 85 % | >= 85 % to < 87 % | >= 87 % to < 91 % | >= 91 % |
| 2025 | PDP | < 85 % | >= 85 % to < 87 % | >= 87 % to < 89 % | >= 89 % to < 93 % | >= 93 % |
| 2024 | MA-PD | < 80 % | >= 80 % to < 84 % | >= 84 % to < 88 % | >= 88 % to < 90 % | >= 90 % |
| 2024 | PDP | < 84 % | >= 84 % to < 87 % | >= 87 % to < 89 % | >= 89 % to < 93 % | >= 93 % |
| 2023 | MA-PD | < 79 % | >= 79 % to < 85 % | >= 85 % to < 88 % | >= 88 % to < 92 % | >= 92 % |
| 2023 | PDP | < 84 % | >= 84 % to < 86 % | >= 86 % to < 88 % | >= 88 % to < 90 % | >= 90 % |
| 2022 | MA-PD | < 80 % | >= 80 % to < 85 % | >= 85 % to < 87 % | >= 87 % to < 91 % | >= 91 % |
| 2022 | PDP | < 84 % | >= 84 % to < 86 % | >= 86 % to < 88 % | >= 88 % to < 90 % | >= 90 % |
| 2021 | MA-PD | < 76 % | >= 76 % to < 80 % | >= 80 % to < 84 % | >= 84 % to < 88 % | >= 88 % |
| 2021 | PDP | < 79 % | >= 79 % to < 82 % | >= 82 % to < 85 % | >= 85 % to < 87 % | >= 87 % |
| 2020 | MA-PD | < 74% | ? 74% to < 78% | ? 78% to < 82% | ? 82% to < 85% | ? 85% |
| 2020 | PDP | < 79% | ? 79% to < 83% | ? 83% to < 85% | ? 85% to < 88% | ? 88% |
| 2019 | MA-PD | < 72% | ? 72% to < 78% | ? 78% to < 81% | ? 81% to < 85% | ? 85% |
| 2019 | PDP | < 82% | ? 82% to < 84% | ? 84% to < 86% | ? 86% to < 88% | ? 88% |
| 2018 | MA-PD | < 72% | ? 72% to < 78% | ? 78% to < 81% | ? 81% to < 86% | ? 86% |
| 2018 | PDP | < 76% | ? 76% to < 80% | ? 80% to < 84% | ? 84% to < 86% | ? 86% |
| 2017 | MA-PD | < 70% | ? 70% to < 76% | ? 76% to < 79% | ? 79% to < 83% | ? 83% |
| 2017 | PDP | < 74% | ? 74% to < 78% | ? 78% to < 82% | ? 82% to < 86% | ? 86% |
| 2016 | MA-PD | < 60% | ? 60% to < 69% | ? 69% to < 75% | ? 75% to < 82% | ? 82% |
| 2016 | PDP | < 75% | ? 75% to < 80% | ? 80% to < 83% | ? 83% to < 95% | ? 95% |
| 2015 | MA-PD | < 69% | ? 69% to < 73% | ? 73% to < 77% | ? 77% to < 81% | ? 81% |
| 2015 | PDP | < 74% | ? 74% to < 79% | ? 79% to < 82% | ? 82% to < 85% | ? 85% |
Lowest-scoring contracts, 2024
| Contract | Parent | Members | Score | Stars | Δ | Shortfall to 4★ | Pctile |
|---|---|---|---|---|---|---|---|
| H5117 Wellcare | Centene Corporation | 0 | 72 | 1 | 0 | 16 | 0% |
| S2874 Humana | Humana Inc. | — | 80 | 1 | 0 | 9 | 0% |
| H3015 Shared Health Dual Plus - DE H3015-001 (HMO D-SNP) | BlueCross BlueShield of Tennessee | — | 74 | 1 | — | 14 | 0% |
| H6379 Clear Spring Health | Group 1001 | — | 76 | 1 | — | 12 | 0% |
| H9414 Commonwealth Care Alliance Massachusetts | Commonwealth Care Alliance, Inc. | — | 76 | 1 | — | 12 | 0% |
| H8176 Molina Healthcare of South Carolina | Molina Healthcare, Inc. | 3,128 | 76 | 1 | −1 | 12 | 0% |
| H7389 HealthSpring | Health Care Service Corporation | 0 | 77 | 1 | — | 11 | 1% |
| H1799 Passport Advantage | Molina Healthcare, Inc. | 2,617 | 77 | 1 | — | 11 | 1% |
| H7559 Molina Healthcare of Virginia | Molina Healthcare, Inc. | — | 77 | 1 | — | 11 | 1% |
| H1848 Wellcare | Centene Corporation | — | 77 | 1 | 0 | 11 | 1% |
| H9861 CCA Health Michigan | Commonwealth Care Alliance, Inc. | — | 78 | 1 | −1 | 10 | 1% |
| H3928 Aetna Medicare | CVS Health Corporation | 4,912 | 78 | 1 | −1 | 10 | 1% |
| H8225 Wellcare by Allwell | Centene Corporation | — | 78 | 1 | −1 | 10 | 1% |
| H3467 ProCare Advantage | First Sacramento Capital Funding LLC | 1,010 | 78 | 1 | −3 | 10 | 1% |
| H9826 Community Health Choice | Harris County Hospital District | 1,224 | 78 | 1 | — | 10 | 1% |
| H9147 Blue Cross and Blue Shield of North Carolina | CuraCor Solutions Corp. | 3,516 | 78 | 1 | −1 | 10 | 1% |
| S6506 Blue Cross Blue Shield of Arizona (AZ Blue) | Blue Cross Blue Shield of Arizona | — | 82 | 1 | −1 | 7 | 2% |
| S6946 Clear Spring Health | Group 1001 | — | 82 | 1 | −1 | 7 | 2% |
| S2668 Farm Bureau Health Plans | Tennessee Rural Health Improvement Association | — | 82 | 1 | 0 | 7 | 2% |
| H6067 CareFirst BlueCross BlueShield Medicare Advantage | CareFirst, Inc. | — | 79 | 1 | −1 | 9 | 2% |
| H2593 Wellpoint | Elevance Health, Inc. | 14,312 | 79 | 1 | −1 | 9 | 2% |
| H7169 Wellcare By Allwell | Centene Corporation | — | 79 | 1 | — | 9 | 2% |
| H4676 Troy Medicare | Troy Holdings, Inc. | 1,654 | 79 | 1 | 0 | 9 | 2% |
| H4094 UnitedHealthcare | UnitedHealth Group, Inc. | — | 79 | 1 | −2 | 9 | 2% |
| H9306 Alterwood Advantage | LifeBridge Health, Inc. | 14,406 | 79 | 1 | — | 9 | 2% |
History
| Star year | Code | Name | Measured | Weight | Source |
|---|---|---|---|---|---|
| 2027 | D08 | Medication Adherence for Diabetes Medications | 01/01/2025 – 12/31/2025 | 3 | Prescription Drug Events |
| 2026 | D08 | Medication Adherence for Diabetes Medications | 01/01/2024 – 12/31/2024 | 3 | Prescription Drug Events |
| 2025 | D08 | Medication Adherence for Diabetes Medications | 01/01/2023 – 12/31/2023 | 3 | Prescription Drug Events |
| 2024 | D08 | Medication Adherence for Diabetes Medications | 01/01/2022 – 12/31/2022 | 3 | Prescription Drug Events |
| 2023 | D08 | Medication Adherence for Diabetes Medications | 01/01/2021 – 12/31/2021 | 3 | Prescription Drug Events |
| 2022 | D08 | Medication Adherence for Diabetes Medications | 01/01/2020 – 12/31/2020 | 3 | Prescription Drug Events |
| 2021 | D10 | Medication Adherence for Diabetes Medications | 01/01/2019 – 12/31/2019 | 3 | Prescription Drug Events |
| 2020 | D10 | Medication Adherence for Diabetes Medications | 01/01/2018 – 12/31/2018 | — | Prescription Drug Events |
| 2019 | D10 | Medication Adherence for Diabetes Medications | 01/01/2017 – 12/31/2017 | 3 | Prescription Drug Events |
| 2018 | D11 | Medication Adherence for Diabetes Medications | 01/01/2016 – 12/31/2016 | 3 | Prescription Drug Events |
| 2017 | D12 | Medication Adherence for Diabetes Medications | 01/01/2015 - 12/31/2015 | 3 | Prescription Drug Events |
| 2016 | D12 | Medication Adherence for Diabetes Medications | 01/01/2014 - 12/31/2014 | 3 | Prescription Drug Events |
| 2015 | D11 | Medication Adherence for Diabetes Medications | 01/01/2013 - 12/31/2013 | 3 | Prescription Drug Events |